AYTU logo

AYTU Aytu BioPharma, Inc.

NASDAQ Capital Market · Drug Manufacturers - Specialty & Generic · Healthcare

$2.66
+0.00 (+0.00%)

Aytu BioPharma, Inc. is a specialized pharmaceutical firm dedicated to advancing and marketing innovative therapeutic drugs and consumer health products, serving both domestic U.S. and international markets. Its commercialized portfolio includes several treatments for Attention Deficit Hyperactivity Disorder (ADHD): Adzenys XR-ODT, prescribed for patients aged 6 and up; Cotempla XR-ODT, tailored f…

Market Cap: $28.91Maytubio.com

Price

No data yet.

Social Signal Score

53
5d
—
30d
52
4 mentions
—
60d
52
4 mentions
—
90d
57
8 mentions
—
news: 8

Analyst Ratings

5 analysts
Buyconsensus
Strong Buy 0Buy 5Hold 0Sell 0Strong Sell 0

Revenue

$14.84M+1769.27%
$607.0K$10.65M$20.69M$30.73M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$0.34
$0.32–$0.35
1 analysts
FY2026
$-1.06-415% YoY
$-1.10–$-1.00
1 analysts
FY2027
$-0.43
$-0.44–$-0.40
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Joshua R. Disbrow
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
76
Beta
0.27
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
-4.68
aytubio.com